Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Michael McGarrity, William Moffitt, Sheli Rosenberg, Michael Ward

Premium

Nanosphere announced in its latest financial report that it has promoted Michael McGarrity to succeed William Moffitt as its new president and CEO. The company also said it has appointed Sheli Rosenberg, Michael Ward, and McGarrity to serve on its board of directors, while Moffitt, William White, Mark Slezak, and Roy Davis have all resigned from the board.

Rosenberg, who served on Nanosphere's board from 2002 to 2012, will be the new chair of the board. McGarrity previously was VP of sales and marketing and chief commercial officer, and he has 24 years of experience in the medical devices industry, including 13 years at Stryker.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.